使:ELISA

Nadezhda G Gumanova1, Natalya L Bogdanova1, Victoria A Metelskaya1

  • 1National Research Center for Preventive Medicine (NRCPM), Moscow, Russia.

Laboratory medicine
|September 11, 2023
PubMed
概括

微阵列血清分析有效地识别了诸如动脉样硬化等疾病的潜在蛋白质生物标志物. 一个1.5倍的蛋白质差异和只有3个微阵列足以进行初始候选者评估.

相关概念视频

Proteomics01:33

Proteomics

A proteome is the entire set of proteins that a cell type produces. We can study proteomes using the knowledge of genomes because genes code for mRNAs, and the mRNAs encode proteins. Although mRNA analysis is a step in the right direction, not all mRNAs are translated into proteins.
Proteomics is the study of proteomes' function. It involves the large-scale systematic study of the proteome to denote the protein complement expressed by a genome. Scientist Mark Wilkins coined the term...
7.4K
DNA Microarrays02:34

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...
17.5K